Silence Therapeutics (SLN) News Today → The Gold Grab of the Century (From Colonial Metals) (Ad) Free SLN Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePause For Effect: Utilize Strategic Silenceforbes.com - May 2 at 10:48 AMNissan to sell tiny Silence Nanocar – and it could come to the UKmsn.com - April 30 at 9:50 PMSilence Therapeutics (LON:SLN) Shares Cross Below 200-Day Moving Average of $535.00americanbankingnews.com - April 30 at 3:46 AMSheryl Sandberg Says ‘Screams Before Silence’ Is the Most Important Work She’s Ever Done: ‘Women’s Bodies Need to Be Protected’ | Videoyahoo.com - April 29 at 11:06 PMBeyond The Numbers: 7 Analysts Discuss Silence Therapeutics Stockmarkets.businessinsider.com - April 22 at 5:26 PMSilence Therapeutics Plc American Depository Share (SLN)nasdaq.com - April 13 at 11:50 AM‘Quiet on Set’ to Launch Fifth Episode ‘Breaking the Silence’ With New Drake Bell Interview and Moremsn.com - March 28 at 2:57 PMSilence Therapeutics plc: Silence Therapeutics Reports Full Year 2023 Financial Results and Recent Business Highlightsfinanznachrichten.de - March 13 at 9:23 AMSilence Therapeutics gains on mid-stage win for lead assetmsn.com - March 13 at 9:23 AMSilence Therapeutics Jumps on Clinical Trialsmsn.com - February 23 at 1:45 PMBroker Revenue Forecasts For Silence Therapeutics plc (NASDAQ:SLN) Are Surging Higherfinance.yahoo.com - February 7 at 9:08 AMIs Silence Golden for This Small-Cap Biotech Stock?realmoney.thestreet.com - January 31 at 12:52 PMSilence Therapeutics to Participate in Fireside Chat at Guggenheim Healthcare Talks 6th Annual Biotechnology Conferencefinance.yahoo.com - January 31 at 7:52 AMAll You Need to Know About Silence Therapeutics PLC Sponsored ADR (SLN) Rating Upgrade to Strong Buymsn.com - January 11 at 1:26 PMSilence Therapeutics PLC Sponsored ADR (SLN) Is a Great Choice for 'Trend' Investors, Here's Whyfinance.yahoo.com - January 5 at 1:20 PMThis Silence Therapeutics Insider Increased Their Holding In The Last Yearfinance.yahoo.com - December 24 at 8:11 AMHere's Why Momentum in Silence Therapeutics PLC Sponsored ADR (SLN) Should Keep goingfinance.yahoo.com - December 15 at 1:02 PMDoes Silence Therapeutics PLC Sponsored ADR (SLN) Have the Potential to Rally 187.05% as Wall Street Analysts Expect?finance.yahoo.com - December 6 at 1:25 PMSilence Therapeutics PLC ADR SLNmorningstar.com - November 21 at 6:07 PMSilence Therapeutics: Bullish Outlook on SLN360 and Future Potential Despite Thalassemia Program Discontinuationmarkets.businessinsider.com - November 16 at 5:52 PMIs This A Miracle Drug For 'Sticky Cholesterol'? Analysts Applaud Safety, Efficacy Of Silence Therapeutics' Heart Disease Candidatemarkets.businessinsider.com - November 1 at 8:22 PMSilence Therapeutics ADRs Rise 22% After Positive Trial Resultsmarketwatch.com - November 1 at 3:22 PMEuropean Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Tradingmsn.com - October 27 at 12:15 PMAT&T Unveils “Sound of Silence” Ad to Tout 5G Football Helmet Partnershipmsn.com - October 14 at 12:12 AMSilence Therapeutics to Participate in Fireside Chat at Chardan’s 7th Annual Genetic Medicines Conferencefinance.yahoo.com - September 26 at 8:27 AMWhere Silence Therapeutics Stands With Analystsmarkets.businessinsider.com - August 17 at 12:14 PMSilence Therapeutics Plc (NASDAQ: SLN)fool.com - June 25 at 3:53 PMThe Latest Analyst Ratings for Silence Therapeuticsmarkets.businessinsider.com - May 11 at 3:28 PMSilence Therapeutics plc: Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Developmentfinanznachrichten.de - March 28 at 10:02 AMSilence Therapeutics plc: Silence Therapeutics to Buyback siRNA Complement Assetsfinanznachrichten.de - March 28 at 10:02 AMSilence Therapeutics to Buyback siRNA Complement Assetsfinance.yahoo.com - March 28 at 10:02 AMSilence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Developmentfinance.yahoo.com - March 28 at 10:02 AMRaquel Leviss breaks her silence, Tom Sandoval finally apologizes to Ariana Madix: Here's the 'Scandoval' latestyahoo.com - March 10 at 11:32 PMSilence Therapeutics to Present at SVB Securities Global Biopharma Conferencefinance.yahoo.com - February 8 at 8:04 AMSilence Therapeutics Appoints J.P. Gabriel as Chief Technical Operations Officerwsj.com - February 6 at 9:52 AMSilence Therapeutics Provides SLN360 and SLN124 Clinical Program Updatesfinance.yahoo.com - January 12 at 6:10 PMSilence Therapeutics plc: Silence Therapeutics Reports Third Quarter 2022 Resultsfinanznachrichten.de - November 10 at 5:46 PMSilence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with Thalassemiafinance.yahoo.com - September 29 at 7:55 AMSilence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conferencefinance.yahoo.com - September 27 at 8:55 AMSilence Therapeutics plc: Silence Therapeutics Announces Pricing of Underwritten Offeringfinanznachrichten.de - August 13 at 10:20 PMSilence Therapeutics PLC ADRwsj.com - July 15 at 11:55 PMSilence Therapeutics (NASDAQ:SLN), Short Interest Reportbenzinga.com - June 17 at 4:10 PMSilence Therapeutics to Participate in Fireside Chat at H.C. Wainwright Global Investment Conferencefinance.yahoo.com - May 18 at 11:23 AMSilence Therapeutics to get $3M from Mallinckrodt as trial application for SLN501 filedseekingalpha.com - March 23 at 9:43 AMSilence Therapeutics and Mallinckrodt Announce Submission of Clinical Trial Application for SLN501finance.yahoo.com - March 23 at 9:43 AMSilence Therapeutics plc: Silence Therapeutics Reports Fourth Quarter and Full Year 2021 Resultsfinanznachrichten.de - March 17 at 10:05 AMSilence Therapeutics Reports FY21 Sales £12.4M Up From £5.5M YoYbenzinga.com - March 17 at 10:05 AMSilence Therapeutics Reports Fourth Quarter and Full Year 2021 Resultsfinance.yahoo.com - March 17 at 10:05 AMSilence Therapeutics granted Orphan Drug status for rare blood disorder candidateseekingalpha.com - February 26 at 7:17 PMSilence Therapeutics Posts First Human Data For Cardiovascular Candidatefinance.yahoo.com - February 9 at 8:31 PM Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. SLN Media Mentions By Week SLN Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLN News Sentiment▼0.300.43▲Average Medical News Sentiment SLN News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLN Articles This Week▼40▲SLN Articles Average Week Get Silence Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PRTC News ERGO News BVXP News OXB News HVO News ARIX News AVCT News ONT News GNS News AMS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:SLN) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchStock-Picking AI Predicts #1 Stock of 2024AltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Silence Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
